Luxtec "proceeding cautiously" in acquisition talks:
This article was originally published in Clinica
Luxtec plans to be acquired by an unnamed medical device company and has formed a non-binding agreement. The Worcester, Massachusetts-based company, which supplies surgical vision products, will not comment further on the deal until a binding agreement is reached or the proposed negotiations terminated. "We are proceeding cautiously and urge investors to do the same," said James Hobbs, Luxtec's president and CEO.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.